Explain the Importance of Chronic Disease Management




O’Connor: Chronic disease management is really the key to health care in my opinion. It’s that 10% of our population that accounts for 75% plus of the spend—that is the problem. Doing wellness programs and telling a healthy person to run more isn’t as impactful to the challenges we have in the health care community and on the health spend of our country.
 
More and more focus needs to be on those chronic patients. Doing whatever we can to improve their outcomes ultimately and balancing out the pharmacy spend versus medical spend and getting the ‘teeter totter’ to tilt a little more in the right direction. 

Most Popular

Related Articles

Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.
Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the impact orphan drugs have had on the specialty pharmaceutical industry.
Steven L. D’Amato, RPh, BSPharm; Arturo Loaiza-Bonilla, MD, MSEd, FACP; Noa Biran, MD; Carl T. Henningson, MD; and Peter L. Salgo, MD, review the advantages of in-office dispensing of oral oncolytics.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.